AMERICAN SOCIETY FOR MICROBIOLOGY

Lobbying for AMERICAN SOCIETY FOR MICROBIOLOGY

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$50,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

District of Columbia

Official filing document

Government bodies contacted 2

HOUSE OF REPRESENTATIVES
SENATE

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Bills named in this filing 10

S 4048
PREDICT Act
HR 5269
RESULTS Act
S 2761
RESULTS Act
HR 1864
Risky Research Review Act
S 854
Risky Research Review Act
HR 2756
National Biotechnology Initiative Act of 2025
S 1387
National Biotechnology Initiative Act of 2025
HR 2582
Expanding Partnerships for Innovation and Competitiveness Act
S 1235
Expanding Partnerships for Innovation and Competitiveness Act
S 2676
Cloud LAB Act of 2025

Lobbying activity 4

Health Issues

Antimicrobial resistance; advanced molecular detection; national wastewater surveillance system (S.4048 - PREDICT Act), PAMA reform: RESULTS Act (H.R. 5269 S.2761)

Budget/Appropriations

Fiscal Year 2027 appropriations for NIH, CDC, NSF, DOE Office of Science, USDA research programs.

Science/Technology

Risky Research Review Act (H.R. 1864, S. 854); National Biotechnology Initiative Act (H.R. 2756/ S. 1387); EPIC Act (H.R. 2582/ S. 1235); Cloud Labs to Advance Biotechnology Act of 2025 (S. 2676);

Agriculture

Microbiome research impact on agricultural sciences.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.